Frederick L Locke Selected Research

Rituximab (Mabthera)

1/2023	ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma.
1/2016	Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frederick L Locke Research Topics

Disease

52	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024 - 12/2017
32	Neoplasms (Cancer) 05/2024 - 09/2013
23	Lymphoma (Lymphomas) 02/2024 - 01/2017
16	Multiple Myeloma 04/2024 - 01/2012
14	Cytokine Release Syndrome 12/2023 - 01/2017
12	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 12/2017
10	Hematologic Neoplasms (Hematological Malignancy) 12/2023 - 01/2017
10	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2022 - 12/2012
8	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2024 - 01/2020
6	Cytopenia 01/2024 - 01/2021
5	Disease Progression 02/2024 - 01/2015
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2024 - 10/2014
5	Infections 01/2023 - 01/2021
4	cell-associated neurotoxicity 12/2023 - 12/2020
4	Inflammation (Inflammations) 04/2023 - 10/2020
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023 - 12/2017
4	Bronchiolitis Obliterans Syndrome 11/2022 - 12/2012
3	Neutropenia 01/2024 - 12/2021
3	Leukemia 12/2023 - 12/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2023 - 01/2020
2	Rare Diseases (Rare Disease) 05/2024 - 10/2023
2	Cardiotoxicity 04/2023 - 12/2019
2	Heart Failure 01/2023 - 12/2019
2	Body Weight (Weight, Body) 01/2020 - 12/2017
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 05/2024
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2023
1	Myocarditis (Carditis) 02/2023
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2023
1	Atrial Fibrillation 01/2023
1	Residual Neoplasm 01/2023
1	Ventricular Tachycardia 01/2023
1	Pneumococcal Infections 01/2023
1	Reinfection 01/2023
1	Sarcoma (Soft Tissue Sarcoma) 01/2023
1	Fatigue 06/2022
1	Pain (Aches) 06/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022

Drug/Important Bio-Agent (IBA)

57	Chimeric Antigen ReceptorsIBA 04/2024 - 01/2017
45	axicabtagene ciloleucelIBA 04/2024 - 01/2017
10	tisagenlecleucelIBA 01/2024 - 01/2020
7	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2024 - 01/2021
6	idecabtagene vicleucelIBA 10/2023 - 12/2022
5	tocilizumab (atlizumab)FDA Link 12/2023 - 12/2019
4	brexucabtagene autoleucelIBA 11/2023 - 01/2020
4	B-Cell Maturation AntigenIBA 10/2023 - 01/2023
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 12/2021
3	ofatumumab FDA Link 02/2024 - 06/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 01/2021
3	Ferritins (Ferritin)IBA 10/2023 - 01/2021
3	CytokinesIBA 04/2023 - 12/2021
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 12/2017
3	GlucocorticoidsIBA 11/2022 - 06/2015
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 12/2012
3	AntigensIBA 01/2020 - 09/2013
2	Lenalidomide (CC 5013)FDA Link 02/2024 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2015
2	SurvivinIBA 11/2023 - 01/2015
2	VaccinesIBA 11/2023 - 09/2013
2	C-Reactive ProteinIBA 10/2023 - 12/2021
2	Interleukin-6 (Interleukin 6)IBA 04/2023 - 01/2021
2	CreatinineIBA 04/2023 - 01/2012
2	Prednisone (Sone)FDA LinkGeneric 01/2023 - 11/2022
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2021
2	Circulating Tumor DNAIBA 01/2023 - 01/2021
2	Rituximab (Mabthera)FDA Link 01/2023 - 01/2016
2	Methotrexate (Mexate)FDA LinkGeneric 07/2015 - 12/2012
2	Sirolimus (Rapamycin)FDA Link 07/2015 - 12/2012
1	Antigen Receptors (Antigen Receptor)IBA 05/2024
1	Glucose (Dextrose)FDA LinkGeneric 04/2024
1	Indicators and Reagents (Reagents)IBA 04/2024
1	Methylprednisolone FDA LinkGeneric 02/2024
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024
1	AlbuminsIBA 12/2023
1	Bendamustine Hydrochloride FDA Link 10/2023
1	Interleukin-15 (Interleukin 15)IBA 04/2023
1	Troponin IIBA 04/2023
1	PolyaminesIBA 01/2023
1	Thrombopoietin ReceptorsIBA 01/2023
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2023
1	hypusineIBA 01/2023
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2023
1	Peptidoglycan (Murein)IBA 01/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Vincristine (Oncovin)FDA LinkGeneric 01/2023
1	FluoroquinolonesIBA 01/2022

Therapy/Procedure

66	Therapeutics 05/2024 - 05/2007
16	Drug Therapy (Chemotherapy) 04/2024 - 01/2019
15	Cell Transplantation 05/2024 - 12/2012
10	Immunotherapy 04/2023 - 09/2013
6	Transplantation 01/2024 - 03/2017
4	Stem Cell Transplantation 07/2023 - 01/2019
3	Homologous Transplantation 11/2021 - 01/2020
2	Length of Stay 01/2023 - 01/2021
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017 - 09/2013
1	Erythrocyte Transfusion 01/2024
1	Organ Transplantation 10/2023
1	Aftercare (After-Treatment) 01/2023
1	Salvage Therapy 01/2023